DITURI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.000
EU - Europa 168
AS - Asia 148
SA - Sud America 33
AF - Africa 1
Totale 1.350
Nazione #
US - Stati Uniti d'America 995
CN - Cina 66
SG - Singapore 60
SE - Svezia 51
BR - Brasile 33
IT - Italia 30
DE - Germania 20
BE - Belgio 17
GB - Regno Unito 16
RU - Federazione Russa 12
FI - Finlandia 11
IN - India 7
JP - Giappone 6
CA - Canada 4
FR - Francia 3
VN - Vietnam 3
BD - Bangladesh 2
AL - Albania 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
LT - Lituania 1
NL - Olanda 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.350
Città #
Fairfield 144
Woodbridge 138
Chandler 114
Ashburn 112
Seattle 66
Houston 60
Cambridge 57
Ann Arbor 56
Wilmington 54
Nyköping 45
Singapore 31
Beijing 20
Brussels 17
Bari 13
Nanjing 13
Lawrence 12
Roxbury 12
San Diego 8
Inglewood 7
London 7
New York 6
Redwood City 6
Tokyo 6
Brooklyn 5
Des Moines 5
Helsinki 5
Jiaxing 5
Los Angeles 5
Washington 5
Dearborn 4
Falls Church 4
Tianjin 4
Boardman 3
Dong Ket 3
Jacksonville 3
Santa Clara 3
Shanghai 3
Toronto 3
Brasília 2
Coimbatore 2
Curitiba 2
Dhaka 2
Fortaleza 2
Grafing 2
Hebei 2
Jinan 2
Nanchang 2
Nürnberg 2
Ostuni 2
Paris 2
Princeton 2
São Paulo 2
Torricella 2
Andaraí 1
Belgrade 1
Boksburg 1
Brindisi 1
Budapest 1
Cambé 1
Chongqing 1
Colombo 1
Concórdia 1
Copenhagen 1
Dublin 1
Esslingen am Neckar 1
Feira de Santana 1
Frankfurt am Main 1
Goiânia 1
Gravataí 1
Groningen 1
Guangzhou 1
Guanhães 1
Guarulhos 1
Handan 1
Hangzhou 1
Hounslow 1
Irecê 1
Itajubá 1
Itaúna 1
Jinhua 1
João Pessoa 1
Kingston 1
Kunming 1
Lages 1
Lanzhou 1
Laranjeiras do Sul 1
Lequile 1
Manila 1
Miami 1
Mongaguá 1
Mumbai 1
North Bergen 1
Norwalk 1
Osasco 1
Ottawa 1
Ouro Branco 1
Pelotas 1
Petrolina 1
Petrópolis 1
Phoenix 1
Totale 1.141
Nome #
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 132
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 123
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 123
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 122
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 116
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 100
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 92
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 88
null 86
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 83
null 75
null 70
Valutazione della percezione del rischio biologico in un gruppo di operatori di igiene dentale in formazione e di ruolo 63
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 36
Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma 34
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 31
Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma 15
Totale 1.389
Categoria #
all - tutte 5.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 38 47 51 24 18 18
2020/2021201 7 20 9 18 11 24 17 20 11 27 13 24
2021/2022111 4 2 2 7 7 14 2 14 10 6 16 27
2022/2023237 28 41 22 29 20 27 2 28 28 1 8 3
2023/2024113 4 14 6 17 13 26 24 2 2 2 1 2
2024/2025162 5 5 18 40 36 53 5 0 0 0 0 0
Totale 1.389